Skip to content
Dose Brief
Menu
No. 51 on the board · Grade C

REMEVi review

REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Visit REMEVi Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $199/mo (starting dose, compounded)
Tirzepatide
From $269/mo (starting dose, compounded)
Coverage
All 50 states
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $199/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

REMEVi scored on our six Brief Score factors. See the methodology.

Price Stability48/100
Supply Reliability88/100
Transparency88/100
Access Breadth90/100
Clinical Oversight87/100
Track Record87/100

What we like

  • The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
  • Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
  • LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
  • Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)

The caveats

  • Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
  • The specific compounding pharmacy is not named (described as 'NPI-verified')
  • A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements

The brief

Best for: Readers who want spanish-speaking patients wanting bilingual, LegitScript-certified compounded GLP-1. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

Ranked #51 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest REMEVi — the realistic shortlist if you're weighing it.

Weighing REMEVi against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs REMEVi, and every desk that outranks it is listed on the REMEVi alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect REMEVi's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on REMEVi's site. Not medical advice; see our disclosure.

← Back to all rankings